1 of 1
Story summary
- Eli Lilly broke ground on a $6.5 billion, 236-acre manufacturing site in Houston, Texas.
- The plant will produce Foundayo (orforglipron), Lilly’s first synthetic oral GLP-1 drug approved in April.
- Lilly expects the facility to create over 600 high-wage jobs and about 4,000 construction jobs.
- Lilly pledged $12.5 million to San Jacinto College for a chemical-synthesis pathway and $2.5 million for scholarships.
- Governor Greg Abbott called the investment Texas’ largest active pharmaceutical ingredient project.